African Heritage PA Caucus
Stay Connected

AHPAC and AZ: NON CME Cardio-Renal Benefits and Clinical Implementation of Dapagliflozin

Posted 8 months ago by Camille Dyer

The Cardio-Renal Benefits and Clinical Implementation of Dapagliflozin.

Goal:  To integrate research, science, and the art of clinical practice to optimize reductions in hospitalizations for HF and CKD progression

 

Speakers: Maria O’Connor PA-C, RD, DCES, Deidre Edwards, Pharm. D. and Ima Vanderpool, DNP, AGPCNP-C

 

Date:  February 01, 2022

Time:  8:00 p.m. ET

Please email ahpacmembership@gmail.com if you are interested in participating.